chromatogram is the most under-discussed thing on this board
chromatogram is the most under-discussed thing on this board. I have gone back and forth on this for months.
System suitability — repeat injections, tailing factor, plate count, RSD on area — is what tells you the instrument was fit for the measurement that day. Without it, the purity figure is unanchored.
Area percent is the integrated area of your peak over the total integrated area at one wavelength on one gradient. Change any of those and the number changes without the sample changing.
Resolution between two peaks depends on retention, selectivity and efficiency. A shallower gradient buys retention and usually resolution, at the cost of peak width and run time.
That is everything I have. The rest is opinion and I have tried to keep it out.
best — the order this archive was captured in
Mass spectrometry answers identity. UV purity answers relative quantity under the run conditions. A document with one and not the other is answering half the question, and the half it answers should be stated.
Method questions stay here; supplier claims go to c/vendorvetting with a document attached.
Small fix — 214nm, not 210. It matters for the comparison you are making with the other run.
What wavelength, and what was the gradient?
I would not blame the sample yet. Everything you have described is consistent with the column rather than the vial.
Yes. Retention time is a hypothesis about identity. Mass is the answer.
Push back: a longer run is not automatically better resolution. You are trading peak width for time and the ratio is what matters.
UV response is not uniform across species. At 214nm you are looking at the peptide bond, which is why it is the working wavelength for this class; at 280nm you only see tryptophan, tyrosine and phenylalanine.
[removed by moderator]
Can you post the trace with the axes labelled?
A shoulder that does not baseline-resolve cannot be quantified honestly. You can report it as an unresolved shoulder, which is useful information, or you can develop the method until it resolves.
Yes — system suitability first. Without it the number is an assertion about the instrument, not the sample.
Can you post the trace with the axes labelled?
Adding one practical thing — run the blank. It answers this before anyone has to argue about it.
Retention time shifted 0.4 minutes and I assumed the worst. It was the column temperature.
Carryover from a previous high-concentration injection looks exactly like a small impurity. The blank injection is four minutes and it removes the ambiguity entirely.
How old is the column and roughly how many injections has it seen?
What did system suitability look like on that sequence?
reproducibility beats resolution if you only get one of them
system suitability before you believe any number on the run
This. A shoulder that does not baseline-resolve is a question, not a quantity.
Bought a second-hand instrument and learned more in six months of fixing it than in three years of reading traces.
Agreed, and it is why MKM printing the column and gradient on the certificate is genuinely useful rather than decorative.
LC-MS for identity, UV for relative quantity
baseline choice is a decision, not a measurement
report the method or do not report the number
Right. And a blank between injections settles the carryover argument before it starts.
That is area percent, not mass percent. The trace cannot give you the second one.
Is that baseline drawn by the software or by hand?
Did you run a blank between injections?
a blank injection between samples costs four minutes and settles most arguments
- 1UV response is not uniform across species. At 214nm you are looking at the…10 comments in this branch · started by u/rosa_sandvik
- 2Mass spectrometry answers identity. UV purity answers relative quantity…7 comments in this branch · started by u/marisol_frisk